Ultima-Selank 10mg Ultima Peptides

£49.00

Selank is a synthetic heptapeptide derived from tuftsin with added C-terminal tripeptide Pro-Gly-Pro. This nootropic research compound modulates GABAergic neurotransmission and IL-6 pathways in preclinical studies, making it valuable for neurological and immunological research applications requiring precise peptide investigation.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima-Selank 10mg Ultima Peptides
Ultima-Selank 10mg Ultima Peptides
£49.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Compound Profile: Ultima-Selank

Selank is a synthetic heptapeptide derived from the naturally occurring tetrapeptide tuftsin, enhanced with an additional C-terminal tripeptide sequence Pro-Gly-Pro. This modification confers improved stability and bioavailability compared to the parent compound. As a tuftsin analogue, Selank has been extensively studied in neurological research models, where it demonstrates modulatory effects on GABAergic neurotransmission pathways and cytokine expression patterns. The compound’s unique structure allows researchers to investigate both immunomodulatory and nootropic mechanisms within controlled laboratory environments. Stroid UK Shop provides this research-grade peptide for advanced in-vitro studies requiring precise neurobiological investigation tools.

Investigational Applications

Laboratory studies have demonstrated Selank’s capacity to modulate interleukin-6 expression levels and influence GABA receptor activity in neural tissue preparations. Researchers examining stress response pathways utilize this peptide to investigate neuroadaptive mechanisms and synaptic plasticity changes. The compound’s interaction with enkephalin-degrading enzymes makes it particularly valuable for studies focusing on endogenous opioid system modulation. Comparative research with other Selank preparations allows scientists to evaluate dosage-dependent responses across different experimental paradigms. Additionally, researchers studying immune-neural crosstalk mechanisms employ Selank to examine bidirectional communication pathways between nervous and immune systems. Its established research profile makes it suitable for both acute and chronic exposure studies in cellular and tissue models. Scientists investigating selective androgen receptor modulators often incorporate Selank as a reference compound for comparative neurological studies, while those working with other research peptides utilize it for multi-target pathway investigations.

Technical Specifications

Ultima-Selank 10mg Technical Data
Parameter Specification
Chemical Name Thr-Lys-Pro-Arg-Pro-Gly-Pro
CAS Registry 129954-34-3
Molecular Weight 751.87 g/mol
Purity Grade ≥98% HPLC verified
Physical State Lyophilised white powder
Storage Temperature 2-8°C protected from light
Solubility Water soluble for reconstitution
Manufacturer Ultima Peptides

Research Compliance Statement

This Ultima-Selank 10mg preparation is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any clinical application. Researchers must ensure proper laboratory protocols, appropriate storage conditions, and compliance with institutional guidelines when handling this research chemical. All studies should be conducted within accredited research facilities by qualified personnel familiar with peptide handling procedures. This product requires proper reconstitution techniques and sterile handling methods to maintain research integrity and experimental validity.

Related